The Democratic Republic of Congo is confronting its deadliest Ebola outbreak to date. Earlier reported totals exceeded 5,100 infections and 2,420 deaths; by 20 October 2026, the World Health Organization (WHO) counted 9,704 confirmed cases and 4,687 deaths, a crude case-fatality ratio of 48.3%. Transmission had spread across 66 health zones in eight provinces: Ituri, Nord-Kivu, Sud-Kivu, Tshopo, Haut-Uélé, Bas-Uélé, Sud-Ubangi and Nord-Ubangi. WHO said, “Sustained, high-level transmission continues in the Democratic Republic of the Congo.”
The outbreak was first detected in May 2026, when laboratory analysis by the Democratic Republic of Congo’s Institut National de Recherche Biomédicale identified Bundibugyo virus. This is a different Ebola virus species from the Zaire virus that drove many previous outbreaks and vaccine responses. The epidemic, initially reported across six eastern and northeastern provinces, had expanded by October to eight provinces, including Wapinda Health Zone in Nord-Ubangi. WHO assessed the risk as “very high” in the DRC, “high” in countries sharing land borders and “low” for the wider African region and globally.
In Bunia, the capital of Ituri province and one of the hardest-hit areas, fear has become part of daily life. Residents such as Hubert Nendakala, who recently lost two family members working in border police, warn that underestimating the threat could have devastating consequences. Ituri accounted for 72.7% of cumulative confirmed cases in WHO regional reporting, although its share was declining as transmission intensified elsewhere, including in Nord-Kivu and Haut-Uélé.
This is the seventeenth Ebola outbreak in DR Congo’s history, and it has already surpassed the 2018 epidemic in fatalities. Its rapid escalation has drawn comparisons with the West African crisis of 2014 to 2016, which claimed more than 11,300 lives. Tom Fletcher, the UN’s humanitarian chief, says a person is dying every 30 minutes in DR Congo from this strain, for which no approved vaccine or treatment currently exists. Existing vaccines target the Zaire strain and are ineffective against Bundibugyo.
WHO Director-General Tedros Adhanom Ghebreyesus has acknowledged that the outbreak remains far from controlled. Many deaths are occurring outside health facilities, in communities, and among people not previously identified as contacts. More than 1,000 patients have recovered after symptomatic treatment. As of 21 October, the European Centre for Disease Prevention and Control reported 1,041 patients hospitalized in isolation. The United Nations said approximately 30,000 contacts were being monitored each day over a three-week period.
Containing transmission remains a major challenge. Dr. Jean Kaseya of Africa CDC reports that 60 to 70% of deaths have occurred in communities rather than hospitals. Uganda, by contrast, halted its Bundibugyo outbreak in July after just a few dozen cases, thanks to early diagnosis and intensive contact tracing. That contrasts sharply with the delayed response in DR Congo. WHO and Africa CDC designated the epidemic a Public Health Emergency of International Concern and a Public Health Emergency of Continental Security on 17 and 18 May, respectively. The two organizations launched a joint continental preparedness and response plan on 5 June.
Hervé Amani, a local governance and human rights advocate, criticizes the authorities’ slow and inadequate response. He argues that the focus should be on anticipating challenges and adapting the response, rather than relying on past experience. Delayed detection has been linked to initial misdiagnoses: early symptoms resemble malaria, typhoid or seasonal flu, while available tests were designed for the Zaire variant and missed Bundibugyo cases.
Response operations also face escalating insecurity and population displacement, while restricted humanitarian access threatens surveillance and contact tracing, WHO says. In Haut-Uélé, seven of the province’s 13 health zones were affected by 19 October, with 421 confirmed cases and 180 deaths. Médecins Sans Frontières supported the expansion of an Ebola treatment centre there from 40 to 50 beds. WHO has announced increased community surveillance, expanded treatment capacity and deeper engagement with local populations to build trust. Clinical trials for two experimental vaccines are underway, while safe and dignified burials are intended to reduce transmission risks during traditional funeral practices.
Thierno Baldé, WHO’s Bundibugyo response lead in DR Congo, says the strategy now centers on decentralizing operations and bringing support closer to affected communities. He cautions that a precise timeline for control is impossible, though the outbreak could be reversed within three months if resources are secured. WHO’s regional reporting described the situation as increasingly challenging: the epidemic was expanding geographically, while access to affected areas remained constrained.
Funding remains a critical obstacle. WHO has received only 60% of the $115 million needed, as international aid has been sharply reduced, particularly following a 70% cut in US health sector funding for DR Congo. Despite this, plans are in place to increase treatment capacity to 3,000 beds and ensure medical staff are properly trained.
The epidemic has also spread beyond the DRC, with imported Bundibugyo-virus cases reported in Kenya and Nigeria. Reuters described the outbreak’s reach across four countries in eastern, basic and western Africa as the widest geographic spread of an Ebola outbreak on the continent to that point. WHO’s risk assessment distinguishes the very high risk within the DRC from the high risk in neighboring countries and low risk for the wider region and globally.
While the Ebola crisis in DR Congo dominates headlines, other humanitarian emergencies in the region continue to draw attention. For example, the rapid expansion of a migrant camp on Ceuta’s El Trampolín beach has highlighted ongoing migration pressures and the challenges of managing public health and safety in border areas, as reported in coverage of the Ceuta settlement situation.
Ebola is a viral hemorrhagic fever transmitted through direct contact with the bodily fluids of infected people. The Bundibugyo virus, first identified in Uganda in 2007, is less well studied than the Zaire virus. The scale and speed of the current outbreak show why rapid detection and community engagement matter, alongside international support. WHO continues to describe transmission in the DRC as sustained and high-level. The risk of further spread depends on containment capacity, access to affected communities and available funding.
